Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrofurantoin vs Fosfomycin in Cystitis
NCT06518291Phase 4Not yet recruiting
- Sponsor
- Shalamar Institute of Health Sciences
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Modality
- Metabolically Activated Prodrugs
01
Overview
Phase 4, randomised, open-label trial in cystitis comparing Nitrofurantoin group with Fosfomycin group (2 arms). Primary endpoint: Clinical response following completion of therapy by history at 7 days. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
nitrofurantoinfosfomycin
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT06518291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06518291.